Shuggah partnered with Alty to localise, enhance, and scale a diabetes management application for a global audience. Through strategic audit, compliance-driven design, and front-end and iOS development, the product evolved into a reliable, sensor-agnostic health platform.
App rating — up from 3.4★
4.7
App Downloads Worldwide
~170K
Global app rating
4.4
About the Client
Shuggah is a health-tech mobile application designed to support insulin-dependent people living with diabetes
The product integrates with a wide range of continuous glucose monitoring (CGM) sensors and provides real-time insights for both patients and healthcare professionals.
The platform operates in a highly regulated medical environment, where accuracy, reliability, and compliance are critical.
As adoption increased, the ability to scale safely across markets while maintaining clinical trust became a primary business constraint rather than a technical one.
The Challenge
Expansion required defensible compliance logic, medical-grade reliability, and scalable architecture capable of surviving clinical and regulatory scrutiny
Many diabetes management apps are constrained by limited hardware compatibility, fragmented data, or regulatory restrictions that prevent safe expansion across markets. These limitations reduce accessibility for patients and limit adoption by healthcare professionals.
For Shuggah, the challenge was to evolve from a sensor-dependent tracking tool into a reliable, regulation-ready health platform that could support daily patient use and professional medical oversight without increasing cognitive or operational burden.
Without a compliance-ready architecture and clinically reliable data handling, Shuggah faced regulatory exposure, limited cross-market deployment, and reduced trust from healthcare professionals — directly constraining scale.
Limited compatibility with diverse glucose sensors restricting accessibility for users worldwide
Complex regulatory requirements across markets, requiring compliance-ready product design
Need for a simple, intuitive interface, suitable for users with different technical skill levels
Ensuring data reliability and clarity, critical for both patient safety and clinical decision-making
Objective
Alty acted as a strategic product, design, and engineering partner, taking ownership of adapting Shuggah for regulated international use while preserving reliability and ease of use. The focus was on building a system that connects patients and clinicians through trustworthy data rather than isolated features.
Alty conducted research and a technical audit of the existing application to understand its limitations, growth potential, and regulatory considerations. The strategy positioned Shuggah as a bridge between patients and healthcare providers by transforming complex CGM data into clear, actionable insights. The product vision centred on reliability, transparency, and instant access, enabling Shuggah to function as a daily ‘control centre’ for diabetes management. Alty consolidated regulatory, technical, and product constraints into a single decision framework, defining a compliance-first direction before execution began.
The Results
Adoption among healthcare professionals strengthened platform credibility and expanded its use beyond consumer tracking into clinical review workflows.
Reduced daily management friction, supporting sustained retention in a chronic-care product environment.
Infrastructure modernization reduced long-term maintenance costs while improving platform stability and scalability
App rating in Ukraine
4.7
App Downloads Worldwide
~170k
New Downloads per week, with 88% coming from organic App Store searches
3000
Global app rating
90%
In regulated health products, compliance architecture is a growth enabler, not a constraint.
Clinical trust is built through data clarity and system reliability, not feature volume.
Scaling medical software requires governance discipline as much as engineering execution.
